Clinical trial
Circulating Tumor DNA Exposure in Peripheral Blood
NCT03517332
Study timeline
Study start (actual)2015-01-01Date precision: day
Registry last updated2018-11-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Colorectal Cancerunresolved
Pancreatic Adenocarcinomaunresolved
Gastric Cancerunresolved
Hepatocellular Carcinomaunresolved
Non-small Cell Lung Cancerunresolved
Bladder Cancerunresolved
Melanomaunresolved
Ovarian Cancerunresolved
Adrenocortical Cancerunresolved
Breast Cancerunresolved
Other Cancerunresolved
Interventions
Sponsors & collaborators
Quantgene Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03517332 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.